Cancer Genetics
Издатель: Elsevier · ISSN 2210-7762 · 58 статей
- Evolution of germline testing, mutation spectrum and clinico-pathological features in male breast cancer: a 27-year retrospective cohort including 69 patients
- Editorial Board
- ISG15 drives cervical cancer progression by hyperactivating the NOD-like receptor signaling pathway
- Enhancing cell type annotation for cancer transcriptomics using retrieval-augmented generation
- Rare and complex three-way t(8;11;21) translocation in core-binding factor acute myeloid leukemia transforming into refractory mediastinal myeloid sarcoma: cytogenetic and molecular insights
- Gut microbiota-metabolite axis in gastric cancer: Genetic causality and Ruminococcus subgroup shifts
- TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process
- Regulation of exosomal miR-513a and miR-149 expression by APE1 in PD-L1 and TCR immune regulation pathways to promote immune evasion in osteosarcoma
- Cytogenomic landscape of adult Philadelphia chromosome-positive acute lymphoblastic leukemia in Malaysia
- A decision-oriented framework for genomic testing across the prostate cancer continuum
- Acquired ring chromosomes in hematological malignancies: A systematic evidence review for diagnostic advances, cytogenomic insights, and clinical significance by an International Consortium on Human Ring Chromosomes (ICHRC) working group
- Molecular etiology and therapeutic advances in retinoblastoma
- Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer
- Identification of a novel class of early exon ALK rearrangements across two pan-tumor sequencing databases
- Beyond ATRX: The heterogeneous basis of Alternative Lengthening of Telomeres in osteosarcoma
- Prohibitins in cancer: Multifaceted regulators of mitochondrial homeostasis, oncogenic signaling, tumor microenvironment, and therapeutic resistance
- An atypical RUNX1::ETV6::RUNX1 fusion in a pediatric patient with precursor B-cell acute lymphoblastic leukemia
- Integrative transcriptomic and CRISPR dependency analysis identifies hepatoblastoma-specific essential genes and actionable vulnerabilities
- Clinical utility and implementation of a virtual molecular tumor board in real-world oncology practice
- Multi-omics analysis identifies altered EOMES-associated differentiation programs of precursor effector-memory CD8⁺ T cells in transplant-associated cutaneous squamous cell carcinoma
- Regression-based clustered CpG methylome profiling reveals divergent epigenetic trajectories in paired primary and recurrent hepatocellular carcinoma
- Germline pathogenic PTEN variant in a patient with a Kaposiform haemangioendothelioma
- Retraction notice to “Ultra-sensitive detection of melanoma NRAS mutant ctDNA based on programmable endonucleases” [Cancer Genetics 294–295 (2025) 47–56]
- Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses
- Methodological considerations regarding the blood DNA methylation signature for ICI response prediction
- Discordant neoplasms in monozygotic twins with a germline RECQL5 variant
- Mechanistic fragmentomics
- Sparse integrative dictionary learning resolves conserved drug-response states in multiple myeloma (MM)
- Functional regulation of midkine (MDK) and its link to cancer
- From genotype to outcome in optic pathway gliomas: Biology, biomarkers, targeted therapy, and future directions